1. Home
  2. SSKN vs RDHL Comparison

SSKN vs RDHL Comparison

Compare SSKN & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Strata Skin Sciences Inc.

SSKN

Strata Skin Sciences Inc.

HOLD

Current Price

$1.30

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$1.19

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSKN
RDHL
Founded
1989
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
3.8M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
SSKN
RDHL
Price
$1.30
$1.19
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
71.5K
68.3K
Earning Date
11-13-2025
09-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,980,000.00
$9,550,000.00
Revenue This Year
N/A
$381.91
Revenue Next Year
$7.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
157.62
52 Week Low
$1.19
$1.01
52 Week High
$3.86
$7.00

Technical Indicators

Market Signals
Indicator
SSKN
RDHL
Relative Strength Index (RSI) 41.87 44.82
Support Level $1.20 $1.10
Resistance Level $1.33 $1.23
Average True Range (ATR) 0.09 0.05
MACD -0.00 0.01
Stochastic Oscillator 23.12 31.25

Price Performance

Historical Comparison
SSKN
RDHL

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: